Abstract:The α-keto acid dehydrogenase complex (KDHc) class of mitochondrial enzymes is composed of four members: pyruvate dehydrogenase (PDHc), α-ketoglutarate dehydrogenase (KGDHc), branched-chain keto acid dehydrogenase (BCKDHc), and 2-oxoadipate dehydrogenase (OADHc). These enzyme complexes occupy critical metabolic intersections that connect monosaccharide, amino acid, and fatty acid metabolism to Krebs cycle flux and oxidative phosphorylation (OxPhos). This feature also imbues KDHc enzymes with the heightened capacity to serve as platforms for propagation of intracellular and intercellular signaling. KDHc enzymes serve as a source and sink for mitochondrial hydrogen peroxide (mtH 2 O 2 ), a vital second messenger used to trigger oxidative eustress pathways. Notably, deactivation of KDHc enzymes through reversible oxidation by mtH 2 O 2 and other electrophiles also modulates the availability of several Krebs cycle intermediates and related metabolites which serve as powerful intracellular and intercellular messengers. The KDHc enzymes also play important roles in the modulation of mitochondrial metabolism and epigenetic programming in the nucleus through the provision of various acyl-CoAs, which are used to acylate proteinaceous lysine residues. Notably, nucleosomal control by acylation is also achieved through PDHc and KGDHc localization to the nuclear lumen. In this review, I discuss emerging concepts in the signaling roles fulfilled by the KDHc complexes. I highlight their vital function in serving as mitochondrial redox sensors and how this function can be used by cells to regulate the availability of critical metabolites required in cell signaling. Coupled with this, I describe in detail how defects in KDHc function can cause disease states through the disruption of cell redox homeodynamics and the deregulation of signaling. Finally, I propose that the intracellular and intercellular signaling functions of the KDHc enzymes are controlled through the reversible redox modification of the vicinal lipoic acid thiols in the E2 subunit of the complexes.

Malate dehydrogenase as a multi-purpose target for drug discovery

Insights into the regulation of malate dehydrogenase: inhibitors, activators, and allosteric modulation by small molecules

Catalytic mechanism and kinetics of malate dehydrogenase

Physiology of malate dehydrogenase and how dysregulation leads to disease

Uncovering malate dehydrogenase: structure, function and role in disease

Malate dehydrogenase (MDH) in cancer: a promiscuous enzyme, a redox regulator, and a metabolic co-conspirator

The structural biology and dynamics of malate dehydrogenases

Exploring the uncharted territory of the potential protein-protein interactions of cytosolic malate dehydrogenase

Malate dehydrogenase: a story of diverse evolutionary radiation

Phosphorylation of mammalian cytosolic and mitochondrial malate dehydrogenase: insights into regulation

A fragment-based approach identifies an allosteric pocket that impacts malate dehydrogenase activity

Acetylation, ADP-ribosylation and methylation of malate dehydrogenase

Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme

Enzymatic Characterization and Coenzyme Specificity Conversion of a Novel Dimeric Malate Dehydrogenase from Bacillus subtilis

Association of the malate dehydrogenase-citrate synthase metabolon is modulated by intermediates of the Krebs tricarboxylic acid cycle

A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration

Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury.

Mitochondrial Targets for Pharmacological Intervention in Human Disease

The potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease

The emerging importance of the α-keto acid dehydrogenase complexes in serving as intracellular and intercellular signaling platforms for the regulation of metabolism.

Aldehyde Dehydrogenases As Promising Targets for Treating Toxic Alde-hyde-related Diseases.